MedTrace Logo

Measurement of vanilloïd Compounds in Urin of Autistic vs Control Patients, as Potential Biomarkers

NCT04651972 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2020-12-03

No results posted yet for this study

Summary

In a former study, four vanilloid compounds were observed increased in the urin of autistic patients. The present study is aimed at performing a ambispective study to confirm or not these preliminary results. 70 urins from autistic children (already collected) will be compared to 70 urins of non autistic children (collected without intervention, remaining sample from the standard care), in terms of measurements of four vanilloid compounds using a GCMS apparatus.

Conditions

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Jean-Luc Olivier, MD, PhD, · CHRU Nancy

Eligibility

Min Age
2 Years
Max Age
14 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2022-07-30
Completion
2022-07-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04651972 on ClinicalTrials.gov